!
!
Sign in / Join ICS
Home
Real-world cardiovascular assessment of mirabegron treatment in patients with overactive bladder and concomitant cardiovascular disease: results of a Japanese post-marketing study
Kato D
1
, Katoh T
2
, Kuwamoto K
1
, Kuroishi K
1
Research Type
Clinical
Abstract Category
Overactive Bladder
Abstract 118
Open Discussion ePosters
Scientific Open Discussion Session 7
Wednesday 14th September 2016
12:40 - 12:45 (ePoster Station 5)
ePoster Area
Overactive Bladder
Prospective Study
Urgency/Frequency
1.
Astellas Pharma Inc,
2.
Cardiovascular Centre, International University of Health and Welfare, Mita Hospital, Tokyo, Japan
Presenter
D
Daisuke Kato
Links
Abstract PDF
Edit Abstract
Abstract Centre
Abstract
26/04/2024 05:11:19